A Study of GZR18 Injection in Chinese Obese/Overweight Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The study was a multicenter, randomized, double-blind, placebo-controlled phase Ib/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of GZR18 injection in Chinese adult obese/overweight patients. This study is divided into Part A and Part B, which are to be conducted simultaneously.
Epistemonikos ID: a980a2b7feb45cda5893c978e48fe0b1168d7ab0
First added on: May 15, 2024